Literature DB >> 2334513

The biology and clinical applications of interleukin 2.

R C Rees, R H Wiltrout.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2334513     DOI： 10.1016/0167-5699(90)90012-x

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  4 in total

1.  Effects of immunization with tumor cells double transfected with interleukin-2 (IL-2) and interleukin-12 (IL-12) genes on artificial metastasis of colon26 cells in BALB/c mice.

Authors:  T Takada; K Kato; H Yagita; H Hamada; K Okumura
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

2.  Evidence that induction and regulation of lymphokine-activated killer (LAK) activity are mediated by changes in tumour-binding potential of lymphocytes after activation by interleukin-2 (IL-2).

Authors:  A Uchiyama; T Morisaki; M Torisu
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

3.  Induction of tumor-specific cytotoxic T lymphocytes and natural killer cells by tumor cells transfected with the interleukin-2 gene.

Authors:  Y Iwanuma; K Kato; H Yagita; K Okumura
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

4.  Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus.

Authors:  J Alcocer-Varela; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.